JP2004501132A5 - - Google Patents

Download PDF

Info

Publication number
JP2004501132A5
JP2004501132A5 JP2002504212A JP2002504212A JP2004501132A5 JP 2004501132 A5 JP2004501132 A5 JP 2004501132A5 JP 2002504212 A JP2002504212 A JP 2002504212A JP 2002504212 A JP2002504212 A JP 2002504212A JP 2004501132 A5 JP2004501132 A5 JP 2004501132A5
Authority
JP
Japan
Prior art keywords
dichloro
alkyl
acid
alkenyl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002504212A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004501132A (ja
Filing date
Publication date
Priority claimed from GBGB0015205.8A external-priority patent/GB0015205D0/en
Application filed filed Critical
Publication of JP2004501132A publication Critical patent/JP2004501132A/ja
Publication of JP2004501132A5 publication Critical patent/JP2004501132A5/ja
Withdrawn legal-status Critical Current

Links

JP2002504212A 2000-06-21 2001-06-15 甲状腺受容体リガンド、それらを含む薬学的組成物、および甲状腺ホルモンにより影響を及ぼされる障害の治療におけるそれらの使用 Withdrawn JP2004501132A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0015205.8A GB0015205D0 (en) 2000-06-21 2000-06-21 Bioisosteric thyroid receptor ligands and method
PCT/EP2001/006815 WO2001098256A1 (en) 2000-06-21 2001-06-15 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones

Publications (2)

Publication Number Publication Date
JP2004501132A JP2004501132A (ja) 2004-01-15
JP2004501132A5 true JP2004501132A5 (https=) 2008-07-10

Family

ID=9894112

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002504212A Withdrawn JP2004501132A (ja) 2000-06-21 2001-06-15 甲状腺受容体リガンド、それらを含む薬学的組成物、および甲状腺ホルモンにより影響を及ぼされる障害の治療におけるそれらの使用

Country Status (8)

Country Link
US (1) US7199265B2 (https=)
EP (1) EP1296936A1 (https=)
JP (1) JP2004501132A (https=)
KR (1) KR20030058952A (https=)
AU (1) AU779880B2 (https=)
CA (1) CA2412161C (https=)
GB (1) GB0015205D0 (https=)
WO (1) WO2001098256A1 (https=)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7163918B2 (en) * 2000-08-22 2007-01-16 New River Pharmaceuticals Inc. Iodothyronine compositions
US20040242594A1 (en) * 2001-11-17 2004-12-02 Dan Peters Prodrugs of antidepressants and their use for treating depressions
GB0208384D0 (en) * 2002-04-11 2002-05-22 Karobio Ab Novel compounds
AU2003257155A1 (en) * 2002-08-02 2004-02-23 The General Hospital Corporation Methods for the production of cells and mammals with desired genetic modifications
FR2858232B1 (fr) * 2003-07-29 2006-03-03 Pierre Potier Utilisation d'un derive de biguanide pour proteger la peau des radiations uvb
CN1882327A (zh) * 2003-11-19 2006-12-20 症变治疗公司 含磷的新的拟甲状腺素药
WO2006128058A2 (en) 2005-05-26 2006-11-30 Metabasis Therapeutics, Inc. Thyromimetics for the treatment of fatty liver diseases
US20070082907A1 (en) * 2003-11-25 2007-04-12 Eli Lilly And Company Peroxisome proliferator activated receptor modulators
WO2005090297A1 (en) * 2004-03-19 2005-09-29 Biotie Therapies Corporation Sulphonamide derivatives
GB0406378D0 (en) * 2004-03-22 2004-04-21 Karobio Ab Novel pharmaceutical compositions
GB0406380D0 (en) * 2004-03-22 2004-04-21 Karobio Ab Novel pharmaceutical compositions
MX2007001215A (es) 2004-08-06 2007-04-17 Otsuka Pharma Co Ltd Compuestos aromaticos.
US20060039890A1 (en) * 2004-08-20 2006-02-23 Renshaw Perry F Treatment of psychological and cognitive disorders using a cholesterol -lowering agent in combination with an antidepressant
RU2007111760A (ru) * 2004-09-01 2008-10-10 Трастиз Оф Бостон Юниверсити (Us) Способ лечения гиперпролиферативного кожного нарушения
WO2006128056A2 (en) * 2005-05-26 2006-11-30 Metabasis Therapeutics, Inc. Novel phosphinic acid-containing thyromimetics
GB0513692D0 (en) * 2005-07-04 2005-08-10 Karobio Ab Novel pharmaceutical compositions
MY146514A (en) 2005-12-05 2012-08-15 Otsuka Pharma Co Ltd Diarylether derivatives as antitumor agents
GB0608724D0 (en) 2006-05-03 2006-06-14 Karobio Ab Novel Pharmaceutical Compositions
MY149934A (en) 2006-08-21 2013-10-31 Array Biopharma Inc 4-substituted phenoxyphenylacetic acid derivatives
UA95978C2 (ru) 2006-10-02 2011-09-26 Оцука Фармас'Ютікел Ко., Лтд. Ингибитор активации stat3/5
GB0725214D0 (en) * 2007-12-24 2008-02-06 Karobio Ab Pharmaceutical compounds
JP2011088826A (ja) * 2008-01-31 2011-05-06 Astellas Pharma Inc 芳香族カルボン酸化合物
TWI534144B (zh) 2009-04-20 2016-05-21 田邊三菱製藥股份有限公司 甲狀腺荷爾蒙β受體作動藥
AU2010303170B2 (en) 2009-10-11 2015-02-26 Rutgers, The State University Of New Jersey Biocompatible polymers for medical devices
US11472918B2 (en) 2012-02-03 2022-10-18 Rutgers, The State University Of New Jersey Polymeric biomaterials derived from phenolic monomers and their medical uses
US9416090B2 (en) 2012-02-03 2016-08-16 Rutgers, The State University Of New Jersey Polymeric biomaterials derived from phenolic monomers and their medical uses
CN107108863B (zh) 2014-12-23 2021-03-19 新泽西鲁特格斯州立大学 生物相容性的碘化二酚单体和聚合物
US10774030B2 (en) 2014-12-23 2020-09-15 Rutgers, The State University Of New Jersey Polymeric biomaterials derived from phenolic monomers and their medical uses
CA3044059A1 (en) 2016-11-21 2018-05-24 Viking Therapeutics, Inc. Method of treating glycogen storage disease
US11707472B2 (en) 2017-06-05 2023-07-25 Viking Therapeutics, Inc. Compositions for the treatment of fibrosis
CA3075877A1 (en) 2017-09-14 2019-03-21 Riken Method for producing retinal tissues
ES3053674T3 (en) 2018-03-22 2026-01-23 Viking Therapeutics Inc Crystalline forms and methods of producing crystalline forms of a compound
WO2020117962A1 (en) 2018-12-05 2020-06-11 Viking Therapeutics, Inc. Compositions for the treatment of fibrosis and inflammation
CN111320609A (zh) 2018-12-13 2020-06-23 拓臻股份有限公司 一种THRβ受体激动剂化合物及其制备方法和用途
KR20210138639A (ko) 2019-03-13 2021-11-19 다이니뽄 스미토모 세이야쿠 가부시키가이샤 이식용 신경 망막의 품질을 평가하는 방법 및 이식용 신경 망막 시트
GEP20247637B (en) 2019-05-08 2024-06-25 Aligos Therapeutics Inc Modulators of thr-b and methods of use thereof
AU2020336272A1 (en) 2019-08-23 2022-04-14 Terns Pharmaceuticals, Inc. Thyroid hormone receptor beta agonist compounds
CN114375193B (zh) 2019-09-12 2024-05-14 拓臻制药公司 甲状腺激素受体β激动剂化合物
EP4201428A4 (en) 2020-09-11 2024-09-11 Sumitomo Pharma Co., Ltd. MEDIUM FOR TISSUE INTENDED FOR TRANSPLANTATION
CA3194226A1 (en) 2020-09-11 2022-03-17 Riken Complex containing neural retina-containing cell aggregates and matrix, and method for manufacturing same
KR20230124556A (ko) 2020-11-06 2023-08-25 알리고스 테라퓨틱스 인코포레이티드 옥신돌 및 이의 사용 방법
WO2023090427A1 (ja) 2021-11-19 2023-05-25 国立研究開発法人理化学研究所 シート状網膜組織の製造方法
US20240398794A1 (en) 2023-04-07 2024-12-05 Terns Pharmaceuticals, Inc. COMBINATIONS OF GLP-1R AND THRß AGONISTS AND METHODS OF USE THEREOF

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB643089A (en) * 1947-10-23 1950-09-15 Glaxo Lab Ltd Improvements in or relating to the preparation of 2:6-dihalogeno diphenyl ethers
GB642159A (en) * 1947-10-23 1950-08-30 Glaxo Lab Ltd Improvements in or relating to the preparation of diphenyl ethers
US3652665A (en) * 1970-04-20 1972-03-28 Merck & Co Inc Halo-phenoxy salicylic acids
US4465508A (en) * 1979-07-18 1984-08-14 Imperial Chemical Industries Plc Diphenyl ether herbicides
EP0580550B1 (en) 1992-07-21 1997-10-22 Novartis AG Oxamic acid derivatives as hypocholesteremic agents
GB9416219D0 (en) 1994-08-11 1994-10-05 Karobio Ab Receptor ligands
DE19527305A1 (de) * 1995-07-26 1997-01-30 Hoechst Ag Substituierte Zimtsäureguanidide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
US5883294A (en) * 1997-06-18 1999-03-16 The Regeants Of The University Of California Selective thyroid hormone analogs
EA004229B1 (ru) * 1999-03-01 2004-02-26 Пфайзер Продактс Инк. Оксаминовые кислоты и их производные в качестве лигандов тиреоидных рецепторов

Similar Documents

Publication Publication Date Title
JP2004501132A5 (https=)
EP1379507B1 (en) HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS
JP2866744B2 (ja) 眼の炎症障害を処置するための３‐ベンゾイルフェニル酢酸誘導体を含む局所的に投与可能な組成物
JP3778516B2 (ja) 新規なアリールプロピオン酸誘導体、その製造方法及び鎮痛薬としてのその用途
RU2001120701A (ru) Новые лиганды тиреоидных рецепторов
JP5927236B2 (ja) 乾癬を予防または低減する方法
RU2006141416A (ru) Пролекарства леводопа, композиции на их основе и их применения
CA2526534A1 (en) Compounds and methods for delivery of prostacyclin analogs
EP2647619B1 (en) Novel compound and medical use thereof
JP2007502806A5 (https=)
JPH09512798A (ja) 消炎、鎮痛および抗血栓活性を有するニトロ化合物およびそれらの組成物
JP2828293B2 (ja) 神経系退行性変質のためのｌ―カルニチン誘導体治療剤
JP2018525430A5 (https=)
JPH07107037B2 (ja) ５α−リダクターゼ阻害活性を有するベンゾイルアミノフェノキシブタン酸誘導体およびそれらを有効成分として含有する薬剤
RU2002101622A (ru) Нафтохиноновые производные и их использование для лечения и борьбы с туберкулезом
UA42686C2 (uk) Похідні 3-хінуклідилових ефірів, проміжні сполуки та спосіб одержання 3-хінуклідилових ефірів, фармацевтична композиція, що має антимускаринову дію, та спосіб лікування хронічних обструктивних захворювань дихальних шляхів або астми
JP2003500466A5 (https=)
EP2265267B1 (en) Compositions comprising n-halogenated or n, n-dihalogenated amine for treatment and prophylaxis of bronchopulmonary infections
MXPA02001740A (es) Uso de bis-sulfonamidas para producir medicinas para la profilaxis o tratamiento de hiperlipidemia.
WO2004112690A2 (en) 2-aminobenzoyl derivatives
RU2005136431A (ru) 4-, 6-или 7-гидроксииндолы с n-оксидными группами и их применение в качестве терапевтических средств
KR980002020A (ko) 오르토-치환된 벤조일구아니딘, 이의 제조방법, 약물 또는 진단제로서의 이의 용도 및 이를 포함하는 약제
JP2003521500A5 (https=)
JP2003523995A5 (https=)
EP0244062A2 (en) Use of aryl ethanol amine derivatives in the treatment of atherosclerosis